Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Nov 2022 07:00 AM
RNS
Holding(s) in Company
10 Nov 2022 07:01 AM
RNS
Filing of Form 10-Q
10 Nov 2022 07:00 AM
RNS
MaxCyte Reports Third Quarter Financial Results
02 Nov 2022 12:05 PM
RNS
Participation in Upcoming Investor Conferences
01 Nov 2022 09:25 AM
RNS
Total Voting Rights
17 Oct 2022 02:58 PM
RNS
Holding(s) in Company
12 Oct 2022 01:00 PM
RNS
Notice of Third Quarter 2022 Financial Results
03 Oct 2022 09:42 AM
RNS
Total Voting Rights and Block Listing Return
28 Sep 2022 01:05 PM
RNS
Signing of Strategic Platform License
21 Sep 2022 01:05 PM
RNS
New Maryland headquarters
08 Sep 2022 07:00 AM
RNS
Morgan Stanley Healthcare Conference Participation
01 Sep 2022 04:39 PM
RNS
Total Voting Rights
11 Aug 2022 07:00 AM
RNS
Second Quarter and Half-Year Results
11 Aug 2022 07:00 AM
RNS
Filing of Form 10-Q for Second Quarter
02 Aug 2022 02:44 PM
RNS
Total Voting Rights
20 Jul 2022 10:00 AM
RNS
Change of Registered Office
15 Jul 2022 01:01 PM
RNS
Notice of Results
12 Jul 2022 01:01 PM
RNS
Signing of Strategic Platform License
12 Jul 2022 07:00 AM
RNS
Grant of Options
08 Jul 2022 05:16 PM
RNS
Holding(s) in Company
01 Jul 2022 07:00 AM
RNS
Total Voting Rights
30 Jun 2022 07:00 AM
RNS
Result of AGM
17 Jun 2022 02:51 PM
RNS
Holdings in Company
06 Jun 2022 07:00 AM
RNS
Publication of Annual Report
27 May 2022 07:00 AM
RNS
Notice of AGM
16 May 2022 07:00 AM
RNS
Inducement Grants
10 May 2022 07:00 AM
RNS
Filing of Form 10-Q
10 May 2022 07:00 AM
RNS
MaxCyte Reports First Quarter Financial Results
04 May 2022 07:00 AM
RNS
Upcoming Investor Conferences
29 Apr 2022 02:41 PM
RNS
Total Voting Rights
19 Apr 2022 07:00 AM
RNS
Inducement Grants Under Nasdaq Listing Rule 5635
13 Apr 2022 07:00 AM
RNS
Departure of CFO and Preliminary Q1 2022 Revenue
11 Apr 2022 07:00 AM
RNS
Holding(s) in Company
01 Apr 2022 07:02 AM
RNS
Total Voting Rights
28 Mar 2022 01:19 PM
RNS
Grant of Options and PDMR Dealing
28 Mar 2022 07:00 AM
RNS
Grant of Options and PDMR Dealing
23 Mar 2022 07:00 AM
RNS
Fourth Quarter and Full Year Financial Results
10 Mar 2022 07:00 AM
RNS
MaxCyte, Names Cenk Sumen Chief Scientific Officer
08 Mar 2022 02:29 PM
RNS
Holding(s) in Company
03 Mar 2022 09:45 AM
RNS
Holding(s) in Company
01 Mar 2022 07:00 AM
RNS
Block Listing Return
24 Feb 2022 01:00 PM
RNS
Notice of Results
22 Feb 2022 03:56 PM
RNS
Holding(s) in Company
21 Feb 2022 07:00 AM
RNS
Consolidation of Trading Lines
14 Feb 2022 01:00 PM
RNS
Upcoming Investor Conferences
14 Feb 2022 07:00 AM
RNS
Inducement Grants Under Nasdaq Listing Rule
01 Feb 2022 07:00 AM
RNS
License with Intima Bioscience
24 Jan 2022 07:30 AM
RNS
Preliminary Unaudited Q4 & FY 2021 Revenue Results
29 Dec 2021 03:30 PM
RNS
Holdings in Company
01 Dec 2021 05:00 PM
RNS
Total Voting Rights
UK 100

Latest directors dealings